On October 14, 2024, Novo Nordisk A/S reported on a share repurchase program initiated on August 7, 2024, aiming to buy back B shares worth DKK 2.4 billion until November 4, 2024; they have already repurchased 2,066,522 shares for DKK 1.8 billion, accumulating a total of 14,462,279 treasury shares, or 0.3% of share capital.